Collectively, our data demonstrated that in lupus microenvironment, UC-MSCs not only increased the number of CD1c+DCs, but also drived CD1c+DCs towards a more tolerogenic phenotype. The gene discussed is CD1C; the disease is systemic lupus erythematosus.